Alerts will be sent to your verified email
Verify EmailNEPHROCARE
|
Nephro Care India
|
Modern Diagnostic
|
Invicta Diagnostic
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
143.87 % | -4.0 % | 36.05 % |
|
5yr average Equity Multiplier
|
18.06 | 4.41 | 1.54 |
|
5yr Average Asset Turnover Ratio
|
1.28 | 1.34 | 1.21 |
|
5yr Avg Net Profit Margin
|
8.51 % | 1.89 % | 20.01 % |
|
Price to Book
|
3.12 | 5.69 | 5.4 |
|
P/E
|
45.76 | 13.13 | 16.2 |
|
5yr Avg Cash Conversion Cycle
|
-60.13 Days | -90.57 Days | 3155.19 Days |
|
Inventory Days
|
6.87 Days | 13.05 Days | 7.26 Days |
|
Days Receivable
|
13.4 Days | 54.11 Days | 14.01 Days |
|
Days Payable
|
75.6 Days | 174.76 Days | -2240.05 Days |
|
5yr Average Interest Coverage Ratio
|
32.99 | 2.75 | 40.66 |
|
5yr Avg ROCE
|
25.8 % | 14.74 % | 37.62 % |
|
5yr Avg Operating Profit Margin
|
13.74 % | 11.93 % | 37.67 % |
|
5 yr average Debt to Equity
|
10.46 | 1.78 | 0.32 |
|
5yr CAGR Net Profit
|
109.59 % | n/a | 82.73 % |
|
5yr Average Return on Assets
|
12.63 % | 1.73 % | 23.37 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
61.47 % | 72.85 % | n/a |
|
Share Pledged by Promoters
|
0.0 | 0.0 | n/a |
|
Change in Promoter Holding (3 Yrs)
|
0.09 % | 0.0 | n/a |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | n/a |
|
Nephro Care India
|
Modern Diagnostic
|
Invicta Diagnostic
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|